Product Information
Registration Status: ActiveSIN15162P
NINLARO CAPSULE 2.3MG is approved to be sold in Singapore with effective from 2017-01-20. It is marketed by TAKEDA PHARMACEUTICALS (ASIA PACIFIC) PTE LTD, with the registration number of SIN15162P.
This product contains Ixazomib Citrate 2.3mg in the form of CAPSULE. It is approved for ORAL use.
This product is manufactured by HAUPT PHARMA AMAREG GMBH in GERMANY, andANDERSONBRECON (UK) LIMITED (TALGARTH) (primary and secondary packager) in UNITED KINGDOM.
It is a Prescription Only Medicine that can only be obtained from a doctor or a dentist, or a pharmacist with a prescription from a Singapore-registered doctor or dentist.
Product Reference
Important Note: For generic product, the SPC/PIL provided may not be brand specific.
{{/items}} {{^items}}Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.